Marina Mitjans
Overview
Explore the profile of Marina Mitjans including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1694
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koller D, Lokhammer S, Goroshchuk O, Denner V, Stiltner B, Mitjans M, et al.
JAMA Psychiatry
. 2025 Feb;
PMID: 39908042
Importance: Although psychological traumas have been associated with endometriosis, limited information is available regarding the role of trauma type and genetic predisposition. Objective: To examine the relationship between traumatic experiences...
2.
Mitjans M, Papiol S, Fatjo-Vilas M, Gonzalez-Penas J, Acosta-Diez M, Zafrilla-Lopez M, et al.
Eur Neuropsychopharmacol
. 2024 Jun;
86:49-54.
PMID: 38941950
Evidence suggests a remarkable shared genetic susceptibility between psychiatric disorders. However, sex-dependent differences have been less studied. We explored the contribution of schizophrenia (SCZ), bipolar disorder (BD) and major depressive...
3.
Herrera-Rivero M, Adli M, Akiyama K, Akula N, Amare A, Ardau R, et al.
Int J Bipolar Disord
. 2024 Jun;
12(1):20.
PMID: 38865039
Background: Lithium (Li) remains the treatment of choice for bipolar disorders (BP). Its mood-stabilizing effects help reduce the long-term burden of mania, depression and suicide risk in patients with BP....
4.
Lithium response in bipolar disorder: Epigenome-wide DNA methylation signatures and epigenetic aging
Zafrilla-Lopez M, Acosta-Diez M, Mitjans M, Gimenez-Palomo A, Saiz P, Barrot-Feixat C, et al.
Eur Neuropsychopharmacol
. 2024 Apr;
85:23-31.
PMID: 38669938
Lithium (Li) is the first-line treatment for bipolar disorder (BD) even though only 30 % of BD patients are considered excellent responders. The mechanisms by which Li exerts its action...
5.
Ou A, Rosenthal S, Adli M, Akiyama K, Akula N, Alda M, et al.
Transl Psychiatry
. 2024 Feb;
14(1):109.
PMID: 38395906
Lithium is the gold standard treatment for bipolar disorder (BD). However, its mechanism of action is incompletely understood, and prediction of treatment outcomes is limited. In our previous multi-omics study...
6.
Koller D, Mitjans M, Kouakou M, Friligkou E, Cabrera-Mendoza B, Deak J, et al.
Psychiatry Res
. 2024 Feb;
333:115758.
PMID: 38335780
We characterized the genetic architecture of the attention-deficit hyperactivity disorder-substance use disorder (ADHD-SUD) relationship by investigating genetic correlation, causality, pleiotropy, and common polygenic risk. Summary statistics from genome-wide association studies...
7.
Herrera-Rivero M, Adli M, Akiyama K, Akula N, Amare A, Ardau R, et al.
Res Sq
. 2023 Dec;
PMID: 38077040
Background: Lithium (Li) remains the treatment of choice for bipolar disorders (BP). Its mood-stabilizing effects help reduce the long-term burden of mania, depression and suicide risk in patients with BP....
8.
Kelsoe J, Ou A, Rosenthal S, Adli M, Akiyama K, Akula N, et al.
Res Sq
. 2023 Oct;
PMID: 37886563
Lithium is the gold standard treatment for bipolar disorder (BD). However, its mechanism of action is incompletely understood, and prediction of treatment outcomes is limited. In our previous multi-omics study...
9.
Herrera-Rivero M, Gutierrez-Fragoso K, Thalamuthu A, Amare A, Adli M, Akiyama K, et al.
Res Sq
. 2023 Jul;
PMID: 37461719
The link between bipolar disorder (BP) and immune dysfunction remains controversial. While epidemiological studies have long suggested an association, recent research has found only limited evidence of such a relationship....
10.
Amare A, Thalamuthu A, Schubert K, Fullerton J, Ahmed M, Hartmann S, et al.
Mol Psychiatry
. 2023 Jul;
28(12):5251-5261.
PMID: 37433967
Lithium is regarded as the first-line treatment for bipolar disorder (BD), a severe and disabling mental health disorder that affects about 1% of the population worldwide. Nevertheless, lithium is not...